Synthesis and antimalarial activity of urenyl Bis-chalcone in vitro and in vivo

References

• Schlitzer M. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics and drugs in clinical development. ChemMedChem 2007;2:944–986.
   PubMed Web of Science ®Google Scholar
• Wiesner J, Ortmann R, Jomaa H, Schlitzer M. New antimalarial drugs. AngewChemInt Ed 2003;42:5274–5293.
   PubMed Web of Science ®Google Scholar
• Talisuma AO, Bloland P, Alessandro UD. History dynamic and public health importance of malaria resistance. ClinMicrobiol Rev 2004;17:236–242.
   Google Scholar
• World Health Organization. World Malaria Report 2009. Geneva, Switzerland: WHO.
   Google Scholar
• Jana S, Paliwal J. Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents 2007;30:4–10.
   PubMed Web of Science ®Google Scholar
• Wernsdorfer WH, Payne D. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 1991;50:95–121.
   PubMed Web of Science ®Google Scholar
• Zhang K, Rathod PK. Divergent regulation of dihydrofolate reductase between malaria parasite and human host. Science 2002;296:545–547.
   PubMed Web of Science ®Google Scholar
• Nielsen SF, Christensen SB, Cruciani G, Kharazmi A, Liljefors T. Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis. J Med Chem 1998;41:4819–4832.
   PubMed Web of Science ®Google Scholar
• Liu M, Wilairat P, Go ML. Antimalarial alkoxylated and hydroxylated chalcones [corrected]: structure-activity relationship analysis. J Med Chem 2001;44:4443–4452.
   PubMed Web of Science ®Google Scholar
• Hayat F, Moseley E, Salahuddin A, Van Zyl RL, Azam A. Antiprotozoal activity of chloroquinoline based chalcones. Eur J Med Chem 2011;46:1897–1905.
   PubMed Web of Science ®Google Scholar
• Hsieh HK, Lee TH, Wang JP, Wang JJ, Lin CN. Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm Res 1998;15:39–46.
   PubMed Web of Science ®Google Scholar
• Araico A, Terencio MC, Alcaraz MJ, Domínguez JN, León C, Ferrándiz ML. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase. Life Sci 2006;78:2911–2918.
   PubMed Web of Science ®Google Scholar
• Sivakumar PM, Geetha Babu SK, Mukesh D. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method. Chem Pharm Bull 2007;55:44–49.
   PubMed Web of Science ®Google Scholar
• Barford L, Kemp K, Hansen M, Kharazmi A. Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines. IntImmunopharmacol 2002;2:545–555.
   PubMedGoogle Scholar
• Rodrigues J, Abramjuk C, Vásquez L, Gamboa N, Domínguez J, Nitzsche B et al. New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer. Pharm Res 2011;28:907–919.
   PubMed Web of Science ®Google Scholar
• Dominguez JN, Leon C, Rodrigues J, Gamboa de Dominguez N, Gut J, Rosenthal PJ. Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities. Eur J Med Chem 2009;44:1457–1462.
   PubMed Web of Science ®Google Scholar
• Domínguez JN, León C, Rodrigues J, Gamboa de Domínguez N, Gut J, Rosenthal PJ. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. J Med Chem 2005;48:3654–3658.
   PubMed Web of Science ®Google Scholar
• Guantai EM, Ncokazi K, Egan TJ, Gut J, Rosenthal PJ, Bhampidipati R et al. Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies. J Med Chem 2011;54:3637–3649.
   PubMed Web of Science ®Google Scholar
• Bukvic Krajacic M, Peric M, Smith KS, Schönfeld ZI, Žiher D, Fajdetic A et al. Synthesis, structure-activity relationship, and antimalarial activity of ureas and thioureas of 15-membered azalides. J Med Chem 2011;54:3595–3605.
   PubMedGoogle Scholar
• Li R, Kenyon GL, Cohen FE, Chen X, Gong B, Dominguez JN et al. In vitro antimalarial activity of chalcones and their derivatives. J Med Chem 1995;38:5031–5037.
   PubMed Web of Science ®Google Scholar
• Deharo E, Gautret P, Ginsburg H, Chabaud AG, Landau I. Synchronization of Plasmodium yoelii nigeriensis and P. y. killicki infection in the mouse by means of Percoll-glucose gradient stage fractionation: determination of the duration of the schizogonic cycle. Parasitol Res 1994;80:159–164.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Haq W, Smilkstein M, Srivastava K, Puri SK, Katti SB. 4-Aminoquinoline derived antimalarials: synthesis, splasmodial activity and heme polymerization inhibition studies. Eur J Med Chem 2010;45:4990–4996.
   PubMed Web of Science ®Google Scholar
• Rosenthal PJ. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp Parasitol 1995;80:272–281.
   PubMed Web of Science ®Google Scholar
• Peters W, Robinson BL. (1999). Malaria. In: Zak O, Sande MA, eds. Handbook of Animal Models of Infection. San Diego, CA, USA: Academic Press, 757–773.
   Google Scholar